drugset / Trial / NCT06266546

Prophylactic Endobronchial Tranexamic Acid to Reduce Bleeding in Transbronchial Cryobiopsy

NCT06266546

Phase 3 Active not recruiting 100 enrolled Youssef Yammine
Non-randomizedSingle-groupOpen-labelPrevention

Summary

Transbronchial cryobiopsies are common procedures used to obtain tissue samples from airways for diagnostic purposes. While these procedures are safe, there is a risk of bleeding from the biopsy site. We are conducting a research study to assess the safety and effectiveness of using tranexamic acid prior to undergoing a transbronchial cryobiopsy.

Timeline

Start
2024-03-01
Primary completion
2025-03-01
Completion
2025-03-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 500 mg Other